PCN134 Effects of Clinical Pharmacist Interventions on Clinical Outcomes in Oncology Patients

Abstract

To assess the effect of clinical pharmacist interventions on the clinical outcomes in oncology patients. A total of 100 patients received their chemotherapy cycles with clinical pharmacy interventions were enrolled in the present study during January 2007 to January 2008. Clinical pharmacy interventions include: Detecting medication errors by using a modified form of the American Society of Hospital Pharmacists (ASHP) worksheet. Correcting those errors and sending recommendations to the medical staff. The clinical pharmacy interventions reduced the number of medication errors from 1548 to 444 which was statistically significant (p=0.004). A total of 1104 clinical pharmacy interventions were documented in this present study. Forty-five percent of clinical pharmacy interventions have led to increase in the efficacy of chemotherapy regimen and 54.7% have led to decrease in the chemotherapy toxicity. Seventy six percent of the errors recorded in the present study occurred in the prescribing stage, about 20 % in the administration stage and 3.8% in the dispensing stage. The clinical pharmacy interventions among oncology patients can reduce the number of medication errors; improve the clinical outcomes through increasing chemotherapy efficacy and reducing the toxicity.